Companies: 10,795·Total market cap: $144.5T
Eiger BioPharmaceuticals, Inc.

Eiger BioPharmaceuticals, Inc.

EIGRQOTCHealthcare
$8.50
+$0.50(+6.25%)
Market Cap$12586800
P/E Ratio—
52W High$16.0
52W Low$1.1
Overview
股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Eiger BioPharmaceuticals, Inc.（EIGRQ）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · EIGRQ · 截至 Jun 8, 2026

关键指标

EPS (TTM)$-50.79eigrq eps ttm · eigrq earnings per shareEarnings history
PE Ratio (TTM)—eigrq pe ratio ttm · eigrq price to earningsPE Ratio deep dive
Revenue (TTM)$15.8Meigrq revenue ttm · eigrq annual revenueFull revenue history
Dividend Yield不分红does eigrq pay dividends · eigrq dividend yieldDividend history
Shares Outstanding1.5Meigrq shares outstanding · eigrq floatShares outstanding history
Next EarningsTBAeigrq earnings date · eigrq next earningsEarnings history

探索 Eiger BioPharmaceuticals, Inc. 数据

eigrq stock data · financials
市值$12.6Meigrq market cap · eigrq valuation
分析师预测—
股息不分红does eiger biopharmaceuticals, inc. pay dividends · eigrq dividend yield
营收$15.8M+16.98%eiger biopharmaceuticals, inc. annual revenue · eigrq revenue
盈利EPS $-50.78+27.19%eigrq earnings · eigrq eps
市盈率—eigrq pe ratio · eigrq price to earnings

财务快照

完整财报
FY 2023Revenue$15.8M▲ +16.98% YoY
202120222023
eiger biopharmaceuticals, inc. revenue · eigrq revenue 2023
FY 2023Net Income-$75.0M▲ +22.54% YoY
202120222023
eiger biopharmaceuticals, inc. net income · eigrq profit 2023
FY 2023EPS$-50.78▲ +27.19% YoY
202120222023
eigrq eps · eiger biopharmaceuticals, inc. earnings per share 2023
TTM:Revenue: $15.8MNet Income: -$75.0MEPS: $-50.79View income statement →

股票表现

完整历史
1D+0.00%
1W+0.00%
1M+0.00%
3M-32.00%
YTD+20.57%
1Y+3.79%
5Y-97.33%

关于 Eiger BioPharmaceuticals, Inc.

CEODavid Apelian
IPO DateJan 30, 2014
Employees25
CountryUS
Websiteeigerbio.com

Eiger BioPharmaceuticals, Inc. is a commercial-stage biopharmaceutical firm dedicated to discovering and advancing treatments for critical health issues, particularly hepatitis delta virus (HDV), amon…

BiotechnologyHealthcareOTCUS

what is eiger biopharmaceuticals, inc. · eigrq stock overview · eiger biopharmaceuticals, inc. company profile · who is eiger biopharmaceuticals, inc. ceo · eigrq OTC · eiger biopharmaceuticals, inc. headquarters · eiger biopharmaceuticals, inc. business segments

关于股票概览与关键数据

Eiger BioPharmaceuticals, Inc.（EIGRQ）是 Biotechnology 行业的 Healthcare 类公司，于 Jan 30, 2014 在 OTC 上市。截至最近交易日，EIGRQ 股价为 $8.50，市值约为 $12.6M。过去12个月累计回报 +3.79%，年初至今回报 +20.57%。

2023 财年 Eiger BioPharmaceuticals, Inc. 营收 $15.8M。完整财务数据（营收历史、盈利、资产负债表）请使用上方标签页。

常见问题

截至最近一个交易日，Eiger BioPharmaceuticals, Inc.（EIGRQ）股价为 $8.50，在 OTC 上市，52周区间为 $1.10 – $16.00。

EIGRQ 最新股价EIGRQ quote todaylive ticker 实时行情
数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议